Completed OBSERVATIONAL NCT04805944

Gut Microbiota, PGx and INSTIs Response

Gut Microbiota, Pharmacogenetics and Integrase Strand Transfer Inhibitors Response

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Updated 6 times since 2021 Last updated: May 8, 2024 Started: Mar 10, 2021 Primary completion: Dec 31, 2023 Completion: Dec 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on HIV Infections, this trial is completed. The trial is conducted by Cliniques universitaires Saint-Luc- Université Catholique de Louvain and has accumulated 6 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jun 2024 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Feb 2023 — Jun 2024 [monthly]

Recruiting
Dec 2021 — Feb 2023 [monthly]

Recruiting

▶ Show 1 earlier version

Apr 2021 — Dec 2021 [monthly]

Recruiting

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Data source: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium